Transfusion Exchanges and Cognition in Sickle Cell Disease
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
- Кому может быть актуально
- Состояния в реестре: Drepanocytosis, Chronic Neurological Deficiency. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Франция
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Effect of Exchange Transfusions on Cognitive Efficiency in Patients With Sickle Cell Disease
Обзор
DREPA-COG is an observational study evaluating the effect of exchange transfusions on cognitive function in adults with severe sickle cell disease (SS or Sβ0). Information processing speed is assessed at three time points during the transfusion cycle using the Symbol Digit Modalities Test (SDMT) and additional validated neuropsychological measures. This minimal-risk, fully remote study aims to identify processing speed as a reproducible marker for clinical monitoring and future therapeutic trials.
Подробное описание
DREPA-COG is a non-interventional, multicenter observational study investigating the effect of exchange transfusions on cognitive performance in adults with severe sickle cell disease (SS or Sβ0). Cognitive complications, including slowed information processing and executive dysfunction, are frequent and disabling in this population. Exchange transfusion, a standard therapy replacing sickled red blood cells with donor cells, may positively influence cognition, but systematic evidence is lacking.
The study evaluates information processing speed as a potential neurological marker across the transfusion cycle. Participants complete three brief neuropsychological assessments remotely by videoconference: before the transfusion, one week after, and prior to the next transfusion. The Symbol Digit Modalities Test (SDMT) is the primary measure, complemented by validated assessments of global cognition, attention, memory, fatigue, mood, and pain.
Primary analysis will use mixed-effects models to assess changes in processing speed over time, adjusting for demographic and clinical covariates. This minimal-risk, fully remote study requires no additional hospital visits and aims to establish processing speed as a reproducible and clinically relevant outcome measure in sickle cell disease.
Первичные конечные точки
- Information Processing Speed [Срок оценки: 48 hours before the transfusion exchange]
- Information Processing Speed [Срок оценки: 7 to 9 days after the transfusion exchange]
- Information Processing Speed [Срок оценки: within 48 hours before the next scheduled transfusion exchange]
Вторичные конечные точки (6)
- Global Cognitive Function - Montreal Cognitive Assessment (Telephone version, T-MoCA) [Срок оценки: Time Point 1 (Baseline): within 48 hours before the scheduled exchange transfusion. Time Point 2 (Post-transfusion): 7 to 9 days after the exchange transfusion. Time Point 3 (End of cycle): within 48 hours before the next scheduled exchange transfusion]
- Fatigue Severity Score (FSS) [Срок оценки: Time Point 1 (Baseline): within 48 hours before the scheduled exchange transfusion. Time Point 2 (Post-transfusion): 7 to 9 days after the exchange transfusion. Time Point 3 (End of cycle): within 48 hours before the next scheduled exchange transfusion]
- Anxiety and Depression Symptoms (Hospital Anxiety and Depression Scale, HADS [Срок оценки: Time Point 1 (Baseline): within 48 hours before the scheduled exchange transfusion. Time Point 2 (Post-transfusion): 7 to 9 days after the exchange transfusion. Time Point 3 (End of cycle): within 48 hours before the next scheduled exchange transfusion]
- Pain Intensity (Numeric Rating Scale, NRS) [Срок оценки: Time Point 1 (Baseline): within 48 hours before the scheduled exchange transfusion. Time Point 2 (Post-transfusion): 7 to 9 days after the exchange transfusion. Time Point 3 (End of cycle): within 48 hours before the next scheduled exchange transfusion]
- Change in Information Processing Speed Measured by the Symbol Digit Modalities Test (SDMT) [Срок оценки: Within 48 hours before exchange transfusion 7-9 days after exchange transfusion Within 48 hours before the next scheduled exchange transfusion]
- Working Memory - WAIS-IV Digit Span Subtest [Срок оценки: Time Point 1 (Baseline): within 48 hours before the scheduled exchange transfusion. Time Point 2 (Post-transfusion): 7 to 9 days after the exchange transfusion. Time Point 3 (End of cycle): within 48 hours before the next scheduled exchange transfusion]
Критерии участия
Критерии включения
- Adults (≥18 years) with severe sickle cell disease (SS or Sβ0).
- Enrolled in a regular monthly transfusion exchange program.
- Not institutionalized.
- No known dementia.
- No severe aphasia.
- Affiliated with or beneficiary of a social security system.
Критерии исключения
- Insufficient mastery of spoken French.
- Severe comorbidities preventing short-term follow-up.
- Known psychiatric disorders.
- Participation in another clinical study with ongoing exclusion periods.
- Lack of adequate computer equipment (minimum 11-inch screen and internet connection).
- Vulnerable patients under legal protection (guardianship or curatorship).
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Франция · 6 центров
- Assistance Publique - Hôpitaux de Paris Hôpital Avicenne — Bobigny
- Hôpital Henri Mondor — Créteil
- Hôpital Kremlin-Bicêtre — Le Kremlin-Bicêtre
- GHU Paris Psychiatrie et Neurosciences - Hôpital Sainte-Anne — Paris
- Assistance Publique - Hôpitaux de Paris Hôpital Necker — Paris
- Centre Hospitalier Saint-Denis — Saint-Denis
Идентификаторы
NCT: NCT07168447 · D24-P021 · IDRCB : 2024-A02851-46